The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index; 22 of the 67 sources its claims cite were checked for support.
Ergogenic properties, safety evaluation and regulations of selected ingredients in testosterone booster dietary supplements
Open accessAbstract
Testosterone boosters (TB) are multi-ingredient dietary supplements that have gained popularity among athletes and the general population. However, certain ingredients in TB are associated with adverse events. The aim of the present study was to analyze dietary TB supplements available for sale online on shop.bodybuilding.com and amazon.com in ten distribution area markets. We evaluated the top five best-selling TB and the most frequently used ingredients of 50 selected TB and the evidence for their efficacy and safety, as well as legislation, statements in the European Union (EU) and sports organizations such as International Olympic Committee (IOC), International Society of Sports Nutrition (ISSN), Australian Institute of Sport (AIS) and World Anti- Doping Agency (WADA). Among 50 TB, 361 components and 98 ingredients were identified. The following ingredients were included in the final review: fenugreek, D- aspartic acid (DAA), 3,3′-diindolylmethane (DIM) or indole-3-carbinol (I3C), Eurycoma longifolia, Cordyceps spp., and ecdysteroids. In EU an authorized health claims refer to few ingredients in TB, mainly minerals, vitamins. Some ingredients were recognized by international sports organizations such as the ISSN, AIS, and WADA and some were identified as unauthorized ingredients/novel food in the EU. Selected ingredients can possibly increase the risk of endocrine system dysregulation.
Overview
CoChat Summary
TL;DR
This review analyzed 50 best-selling testosterone booster (TB) dietary supplements from online markets and evaluated selected ingredients for ergogenic effects, safety, and regulatory status. It found limited or inconsistent human evidence for most reviewed ingredients, with label discrepancies and possible endocrine-system risks.
Key findings
- Across 50 TB supplements, 361 components and 98 different ingredients were identified, averaging 7.22 ingredients per product. The most common ingredients were zinc (64%), Maca (52%), vitamin B6 (50%), fenugreek (46%), *T. terrestris* (32%), DIM/I3C (32%), black pepper (30%), vitamin D3 (28%), magnesium (26%), vitamin B12 (22%), and DAA and *E. longifolia* (20% each).
- DAA showed positive testosterone effects in only one cited human study (43 participants; 3.12 g/day for 12 days increased testosterone and luteinizing hormone by 42% and 33%), while later studies found no effect; 6 g/day reduced testosterone by 12.5% in one study. DAA was classified as ISSN category III and has no authorized EFSA/EC health claims.
- Ecdysterone studies were inconsistent: one 10-week trial reported improved anthropometric and performance parameters at 12 mg and 48 mg daily, but the actual capsule content was 6 mg versus 100 mg declared. Ecdysterone is under WADA monitoring and ISSN category III; some ecdysteroid supplements contained undeclared prohibited AAS.
- *E. longifolia* was reported to increase testosterone in some studies, including 200 mg/day for 4 weeks in late-onset hypogonadism and 600 mg/day for 2 weeks in young men, but the text notes possible effects on estradiol and HPA rather than aromatase inhibition.
Methods
- Market analysis was conducted from June 16, 2022, to September 16, 2022, using shop.bodybuilding.com and amazon.com across ten distribution markets; searches used “testosterone booster” in English and local languages.
- Stage I identified the top five best-selling TB per market, selected 50 supplements, and evaluated label compositions; ingredients with at least 10% prevalence were included, while vitamins, minerals, Maca, *Tribulus terrestris*, *Panax ginseng*, and L-arginine were excluded.
- Stage II searched PubMed over the same period with terms for DAA, ecdysteroids, *Eurycoma longifolia*, indole-3-carbinol/DIM, fenugreek, *Cordyceps*, and related compounds, plus additional Google Scholar records; final reviewed ingredients were fenugreek, DAA, DIM/I3C, *E. longifolia*, *Cordyceps* spp., and ecdysteroids.
Limitations
- The provided text does not state an explicit limitations section.
- Evident from the text: supplement composition was based on labels, and the review itself notes label discrepancies and undeclared substances in some ecdysteroid products.
- Evident from the text: the market analysis was limited to two online retailers and ten markets over a three-month period, and many cited human studies were small, inconsistent, or of poor quality.
Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
18 Valid · 4 Not valid · 32 Not checked · 20 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Analysis of dietary supplements showed that ecdysterone levels ranged from 5 to 383 mg/g.[Citation54]”
What the sources say
- Partly supportedcites [54] sourceExperimental — accuracy not yet measured
Section 3.5 reports measured ecdysterone content in 21 dietary supplements and says it varied substantially between products and batches. The passages retrieved do not establish the claimed range of 5–383 mg/g; the section instead gives a highest amount of 34.1 mg per capsule, which is a different measure. (LLM, conf=0.83)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Certain TB components may be linked to coagulation and pancreatic disorders.[Citation11]”
What the sources say
- Supportedcites [11] source
The paper states on p. 1 that certain testosterone-booster components may be linked to coagulation and pancreatic disorders. Its Conclusions (p. 10) similarly caution that several components may cause coagulation and pancreatic problems, while noting that safety data are scarce. (LLM, conf=0.95)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“DAA was classified as category III as a substance with little to no evidence to support the efficacy and/or safety of the ISSN recommendations.[Citation18]”
What the sources say
- Supportedcites [18] source
In the Background section, D-aspartic acid appears under “Little to no evidence to support efficacy and/or safety.” The “Classifying and categorizing supplements” section explicitly identifies that heading as category III, supporting the attributed classification. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Most of dietary supplements have an actual content of ecdysteroids (determined analytically) that deviates from the concentration stated on the label.[Citation56]”
What the sources say
- Could not verifycites [56] sourceExperimental — accuracy not yet measured
The Introduction says ecdysteroids are marketed as dietary supplements, but does not compare their measured content with label claims. The Methods and Results examine anabolic effects in cells and rats, not supplement composition. Searches for analytically determined content and declared label amounts found no relevant passage in our copy. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“DAA can influence all components of the hypothalamic–pituitary–gonadal (HPG) axis.”
What the sources say
- Supportedcites [21] source
The Introduction states that mammalian studies indicate D-aspartic acid can influence the HPG axis at the hypothalamus, anterior pituitary, and testes—the three components named by the claim. It presents this as evidence from mammalian studies, not as a finding established by this trial in men. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
54 more claims · 13 with their cited sources checked
Create a free account to see all 74 claims and every source verdict.
- It may state two separate claims as one. 13
- Probably not a substantial claim. 2
Citations
Cites
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 1×
“…may be especially interested in TB, considering the well-established relationship between testosterone levels and strength, power, and speed [2,3] as well as increased awareness of low-testosterone-associated relative energy deficiency in sports and its prevalence among both amateur and…”
ISSN exercise & sports nutrition review update: research & recommendations
Kerksick, C. M., Wilborn, C. D., Roberts, M. D., Smith-Ryan, A., Kleiner, S. M., Jäger, R., Collins, R., Cooke, M., Davis, J. N., Galvan, E., et al. (2018) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-018-0242-y · Cited by 945 · cited 6×
“[16,18,19] In the EU, health claims associated with I3C or DIM have not been authorized by the EFSA and EC.”
InfluentialIOC Consensus Statement: Dietary Supplements and the High-Performance Athlete
Maughan, R. J., Burke, L. M., Dvorak, J., Larson-Meyer, D. E., Peeling, P., Phillips, S. M., Rawson, E. S., Walsh, N. P., Garthe, I., Geyer, H., et al. (2018) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.2018-0020 · Cited by 540
Cordyceps – A traditional Chinese medicine and another fungal therapeutic biofactory?
Paterson, R. R. M. (2008) · Phytochemistry · doi:10.1016/j.phytochem.2008.01.027 · Cited by 485
Molecular Targets and Anticancer Potential of Indole-3-Carbinol and Its Derivatives
Aggarwal, B. B., & Ichikawa, H. (2005) · Cell Cycle · doi:10.4161/cc.4.9.1993 · Cited by 434
Medicinal uses of the mushroom Cordyceps militaris: Current state and prospects
Das, S. K., Masuda, M., Sakurai, A., & Sakakibara, M. (2010) · Fitoterapia · doi:10.1016/j.fitote.2010.07.010 · Cited by 408
(2004) · International Journal of Sports Medicine · doi:10.1055/s-2004-819955 · Cited by 344
Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane
Chen, I. (1998) · Carcinogenesis · doi:10.1093/carcin/19.9.1631 · Cited by 285
Selected herbals and human exercise performance
Bucci, L. R. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.624s · Cited by 274 · cited 3×
“[149,170] 167–169] The RUCAM system is the primary tool used for assessing causality in cases of drug-or herb-induced liver injury (DILI or HILI, respectively).”
D‧Aniello, A., Di Fiore, M. M., Fisher, G. H., Milone, A., Seleni, A., D'Aniello, S., Perna, A. F., & Ingrosso, D. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.5.699 · Cited by 227
Research works printed but not linked: 11
- 10.1056/NEJMOA1206168/SUPPL_FILE/NEJMOA1206168_DISCLOSURES.PDF · doi:10.1056/nejmoa1206168/suppl_file/nejmoa1206168_disclosures.pdf
- 10.1152/JAPPLPHYSIOL.00802.2011/ASSET/IMAGES/LARGE/ZDG0011298840007.JPEG · doi:10.1152/japplphysiol.00802.2011/asset/images/large/zdg0011298840007.jpeg
- 10.1186/1477-7827-7-120/FIGURES/4 · doi:10.1186/1477-7827-7-120/figures/4
- 10.1186/S12970-015-0078-7/TABLES/2 · doi:10.1186/s12970-015-0078-7/tables/2
- 10.1007/S00204-019-02490-X/FIGURES/6 · doi:10.1007/s00204-019-02490-x/figures/6
- 10.1186/S12970-020-00390-5/SUPPL_FILE/RSSN_A_12130197_SM0008.DOCX · doi:10.1186/s12970-020-00390-5/suppl_file/rssn_a_12130197_sm0008.docx
- 10.1007/S11419-019-00504-Y/FIGURES/8 · doi:10.1007/s11419-019-00504-y/figures/8
- 10.1186/1550-2783-10-28/FIGURES/3 · doi:10.1186/1550-2783-10-28/figures/3
- 10.1210/EN.20091028 · doi:10.1210/en.20091028
- 10.1158/1055-9965.EPI-13-0645/67686/AM/URINARY-3-3-DIINDOLYLMETHANE-A-BIOMARKER-OF · doi:10.1158/1055-9965.epi-13-0645/67686/am/urinary-3-3-diindolylmethane-a-biomarker-of
- Jędrejko, K.; Lewandowska-Pachecka, S.; Muszyńska, B. Selected Substances Such as Potential or Proven Ergogenic Aid. Med. Sport. 2021, 22(2).
Cited by
Bridging Gaps: AI-Driven Accessibility in Language Education
Asrifan, A., Shafa, S., Pratiwi, W. R., Bahri, A., Siregar, S. R., & Ingilan, S. S. (2025) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3693-7260-9.ch006 · Cited by 7
Jędrejko, M., Jędrejko, K., Granda, D., Kała, K., Pokrywka, A., & Muszyńska, B. (2026) · Nutrients · doi:10.3390/nu18050781 · Cited by 7
Self-citationPhytoecdysteroids from Silene popovii
Yusupova, U. Y., & Usmanov, D. A. (2025) · Springer eBooks · doi:10.1007/978-3-642-36202-6_298-1
Metadata
- Authors
- Jędrejko, K., Lazarev, A., Jędrejko, M., & Muszyńska, B.
- Affiliations
- Jagiellonian University (PL)
- Mount Sinai Hospital (CA)
- Corresponding author
- Muszyńska, Bożena
- Venue
- Food Reviews International
- Publisher
- Informa UK Limited
- Published
- 2023-10-16
- Volume
- 40
- Issue
- 7
- Pages
- 1825-1853
- ISSN
- 1525-6103 (ISSN-L)
- 8755-9129
- OpenAlex
- W4387671680
- Cited by
- 4
- References
- 144
- Citations by year
- 2026: 1 · 2025: 3
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Food Reviews International (publishedVersion, cc-by)
- Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by-nc-nd)
- Funders
- no external funding
- Topics
- Social Sciences › Sociology and Political Science › Doping in Sports
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Pharmacological Effects and Assays
- Keywords
- dietary supplements, supplement ingredients, ergogenic aids, supplement safety, endocrine disruption, fenugreek, D-aspartic acid, 3,3'-diindolylmethane, indole-3-carbinol, Eurycoma longifolia, Cordyceps, ecdysteroids, health claims, novel foods, doping regulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ergogenic properties, safety evaluation and regulations of selected ingredients in testosterone booster dietary supplements. https://app.cochat.ai/papers/10.1080/87559129.2023.2238055
- The paper
- Jędrejko, K., Lazarev, A., Jędrejko, M., & Muszyńska, B. (2024). Ergogenic properties, safety evaluation and regulations of selected ingredients in testosterone booster dietary supplements. Food Reviews International. https://doi.org/10.1080/87559129.2023.2238055
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.